For example the development of cholinesterase inhibitors for the treatment of AD was largely based on the observation that in AD cholinergic neurons are severely depleted and cholinesterase and choline acetyl transferase activity are markedly reduced compared to controls. Here, BCHE is linked to Alzheimer disease.